Use of nasal mupirocin for eradicating meticillin-resistant Staphylococcus aureus: a dilemma?
Afghani
B
B
Kong
V
V
Wu
F L
FL
D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D002983:Clinical Competence; D019538:Health Care Surveys; D006801:Humans; D017053:Infection Control / Q000379:methods*; D016357:Infection Control Practitioners / Q000193:education; D016106:Methicillin Resistance / Q000187:drug effects*; D016712:Mupirocin / Q000008:administration & dosage; D009296:Nasal Cavity / Q000187:drug effects / Q000382:microbiology; D010372:Pediatrics; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013211:Staphylococcus aureus / Q000187:drug effects*
D000900:Anti-Bacterial Agents; D016712:Mupirocin